Skip to main content
PMC home page
Nature Portfolio logoLink to Nature Portfolio
. 2021 Mar 8;35(4):1225. doi: 10.1038/s41375-021-01195-4

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Jing Quan Lim 1,2,3,#, Dachuan Huang 2,3,#, Tiffany Tang 4,#, Daryl Tan 5,6,#, Yurike Laurensia 2, Rou-Jun Peng 1, Esther Kam Yin Wong 2, Daryl Ming Zhe Cheah 2, Burton Kuan Hui Chia 2, Jabed Iqbal 7, Nicholas Francis Grigoropoulos 6, Maarja-Liisa Nairismägi 2, Cedric Chuan Young Ng 8,9, Vikneswari Rajasegaran 8,9, Huangming Hong 1,10, Seok Jin Kim 11, Junhun Cho 12, Eric Tse 13, Benjamin Mow 14, Qi-Chun Cai 15, Li-Mei Poon 16, Qing-qing Cai 1, Jing Tan 1,2,8, Jason Yongsheng Chan 4, Johnathan Xiande Lim 7, Yeow Tee Goh 6, Colin Phipps 6, Olaf Rötzschke 17, Chee Leong Cheng 7, Jeslin Chian Hung Ha 18, Lay Poh Khoo 18, Yvonne Su Ming Loh 5,6, Rex Au-Yeung 19, Thomas Sau-Yan Chan 13, Yok-Lam Kwong 13, William Hwang 20, Won Seog Kim 11, Jin-Xin Bei 1, Tongyu Lin 1,10,✉, Choon Kiat Ong 2,21,22,✉, Soon Thye Lim 20,23,✉
PMCID: PMC8182767  PMID: 33686199

Correction to: Leukemia

10.1038/s41375-020-1000-0

The authors did not declare a relevant conflict of interest thus wish to publish a correction to add this:

Compliance with ethical standards

Conflict of interest

JQL, CKO and STL are co-inventors of the patent filed under International Application No. PCT/SG2018/050509 by Singapore Health Services Pte Ltd which is related to this work. At the time of writing, the co-inventors did not receive honoraria for this work. The patent has been licensed to Lucence (did not take part in this study).

Footnotes

The original article can be found online at 10.1038/s41375-020-1000-0.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Jing Quan Lim, Dachuan Huang, Tiffany Tang, Daryl Tan

These authors jointly supervised this work: Jin-Xin Bei, Tongyu Lin, Choon Kiat Ong, Soon Thye Lim

Contributor Information

Tongyu Lin, Email: tongyulin@hotmail.com.

Choon Kiat Ong, Email: cmrock@nccs.com.sg.

Soon Thye Lim, Email: lim.soon.thye@singhealth.com.sg.

Articles from Leukemia are provided here courtesy of Nature Publishing Group

RESOURCES